These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
982 related items for PubMed ID: 10897123
1. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. Wuchter C, Leonid K, Ruppert V, Schrappe M, Büchner T, Schoch C, Haferlach T, Harbott J, Ratei R, Dörken B, Ludwig WD. Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123 [Abstract] [Full Text] [Related]
2. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program. Willman CL. Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958 [Abstract] [Full Text] [Related]
3. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia. Ludescher C, Eisterer W, Hilbe W, Gotwald M, Hofmann J, Zabernigg A, Cianfriglia M, Thaler J. Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774 [Abstract] [Full Text] [Related]
6. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies. Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H. Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246 [Abstract] [Full Text] [Related]
7. P-glycoprotein expression in adult acute myeloid leukemia: correlation with induction treatment outcome. Tóthová E, Elbertová A, Fricová M, Kafková A, Hlebasková M, Svorcová E, Stecová N, Guman T, Raffac S. Neoplasma; 2001 Feb; 48(5):393-7. PubMed ID: 11845985 [Abstract] [Full Text] [Related]
16. Multidrug resistance of acute leukemia and a strategy to overcome it. Motoji T, Motomura S, Wang YH. Int J Hematol; 2000 Dec 01; 72(4):418-24. PubMed ID: 11197207 [Abstract] [Full Text] [Related]
17. BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia. Kornblau SM, Vu HT, Ruvolo P, Estrov Z, O'Brien S, Cortes J, Kantarjian H, Andreeff M, May WS. Clin Cancer Res; 2000 Apr 01; 6(4):1401-9. PubMed ID: 10778970 [Abstract] [Full Text] [Related]
18. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML). Graf M, Reif S, Hecht K, Pelka-Fleischer R, Kroell T, Pfister K, Schmetzer H. Ann Hematol; 2005 May 01; 84(5):287-97. PubMed ID: 15592672 [Abstract] [Full Text] [Related]
19. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia. Tamm I, Richter S, Oltersdorf D, Creutzig U, Harbott J, Scholz F, Karawajew L, Ludwig WD, Wuchter C. Clin Cancer Res; 2004 Jun 01; 10(11):3737-44. PubMed ID: 15173080 [Abstract] [Full Text] [Related]
20. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia. Suárez L, Vidriales B, García-Laraña J, López A, Martínez R, Martín-Reina V, Tormo M, González-San Miguel JD, Lavilla E, García-Boyero R, Orfao A, San Miguel JF, PETHEMA Cooperative Group. Haematologica; 2001 Dec 01; 86(12):1287-95. PubMed ID: 11726321 [Abstract] [Full Text] [Related] Page: [Next] [New Search]